Biopharmaceutical therapy for treatment of Primary Hyperoxaluria

Project Information

ELIMOX

Grant agreement ID: 606528

Closed project

Start date 1 October 2013

End date 30 September 2016

Funded under

• Specific Programme "Capacities": Research for the benefit of SMEs

Total cost € 2 789 039,00

EU contribution € 2 190 998,00

Coordinated by

OXTHERA AB
Sweden